相关实验视频
Updated: Jul 24, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
515
在生殖年龄的妇女中药理治疗肥胖症
Akua Nuako1, Lucy Tu2,3, Karen J Campoverde Reyes4,5
1Department of Medicine, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114, USA.
Current obstetrics and gynecology reports
|July 10, 2023
概括
抗肥胖药物 (AOM) 有效地帮助减肥,但对人类生育能力,怀孕和母乳养的安全性数据有限. 更多的研究对生育年龄妇女至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生殖健康 生殖健康
- 肥胖医学 肥胖医学
背景情况:
- 肥胖患病率的增加需要有效的体重管理策略.
- 抗肥胖药物 (AOM) 越来越多地用于成人减肥.
- 人们对AOM对生殖健康的影响存在担忧.
研究的目的:
- 审查有关AOM减肥功效的文献.
- 研究AOM对人类生育能力,怀孕和母乳养的影响.
- 确定在给生育年龄的妇女开处方AOM的特殊考虑因素.
主要方法:
- 对AOMs现有研究的文献综述.
- 分析AOM对减肥结果的影响.
- 在生殖环境中评估AOM安全数据.
主要成果:
- AOMs在减肥方面表现出有效性.
- 有限的人类数据存在于怀孕和哺乳期间的AOM.
- 一些AOM可能会影响生育能力或荷尔蒙避孕药的有效性.
- 动物研究表明,对一些AOMs有潜在的原性作用.
结论:
- 由于潜在的风险,大多数AOM在怀孕/母乳养期间不建议使用.
- 给生育年龄的妇女处方AOM需要仔细考虑生殖益处和生殖风险.
- 需要进一步的研究来澄清AOM对生育年龄妇女的风险和益处.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
275
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
275
Obesity
542
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
542
Oral Hypoglycemic Agents: Biguanides and Glitazones
236
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
236
Drugs for Treatment of Constipation-Predominant IBS
219
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
219
Psychosis: Goals of Pharmacotherapy
170
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
170
Hormonal Control of the Ovarian Cycle
585
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
585

